Description
In this episode, Katherine E. Bliss is joined by Ben Hubbard, co-founder, and CEO of Parsyl Inc. As the global race to access Covid-19 vaccines heats up, keeping products cold and ensuring their safe delivery to populations that need them becomes ever more important. Assessing the risks to vaccines during critical periods of transit, storage, and distribution, particularly in lower and middle-income countries that may have limited refrigeration infrastructure, involves real-time data analysis and the use of sensors to detect and transmit information about vaccine temperatures. Ben describes the insurance market for vaccines, the public-private partnerships that are forming around Covid-19 vaccine distribution, and the work Parsyl is doing to solve the quality challenges of moving billions of dollars of life-saving products to every corner of the globe.
Ben is the co-founder and CEO of Parsyl Inc. and formerly served as Chief of Staff at USAID and as the director of USAID’s credit financing division, the Development Credit Authority.
Katherine is joined by Jeffrey L. Sturchio, Senior Associate (Non-Resident) with the CSIS Global Health Policy Center and co-author of the new report, The Ending the HIV Epidemic in the U.S. Initiative: An Interim Assessment and Policy Recommendations. The EHE initiative began in 2019 with a goal...
Published 12/16/22
Dr. Heidi Larson, co-founder of the Global Listening Project and founding director of the Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine, joins Katherine to discuss the impacts of Covid-19 on global vaccine confidence and the importance of listening closely to...
Published 10/28/22